Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents

Journal of Medicinal Chemistry

Volumn 46, Issue 16, 2003, Pages 3546-3554

  Roberti, Marinella ^a   Pizzirani, Daniela ^a   Simoni, Daniele ^b   Rondanin, Riccardo ^b   Baruchello, Riccardo ^b   Bonora, Caterina ^b   Buscemi, Filippo ^c   Grimaudo, Stefania ^c   Tolomeo, Manlio ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Divisione di Ematologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4',5 TRIMETHOXY 3' AMINOSTILBENE; 3,4',5 TRIMETHOXY 3' HYDROXYSTILBENE; 3,5 DIHYDROXY 3' AMINO 4' METHOXYSTILBENE; 3,5,3' TRIHYDROXY 4' METHOXYSTILBENE; ANTINEOPLASTIC AGENT; CISPLATIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUOROURACIL; PHYTOALEXIN; RESVERATROL; RHAPONTIGENIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG CONFORMATION; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SCREENING; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; ISOMERISM; LEUKEMIA CELL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; ISOMERISM; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0041342053     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030785u     Document Type: Article

References (46)

1. Hart, J. H. Role of Phytostilbenes in Decay and Disease Resistance. Annu. Rev. Phytopathol. 1991, 19, 437-458.
2. Burns, J.; Yokota, T.; Ashihara, H.; Lean, M. E. J.; Crozier, A. Plants Foods and Herbal Sources of Resveratrol. J. Agric. Food Chem. 2002, 50, 3337-3340.
3. Soleas, G. J.; Diamandis, E. P.; Goldberg, D. M. Resveratrol: A Molecule Whose Time Has Come? And Gone? Clin. Biochem. 1997, 30, 91-113.
4. Fremont, L. Biological Effects of Resveratrol. Life Sci. 2000, 66, 663-673.
5. Pace-Asciak, C. R.; Hahn, S.; Diamandis, E. P.; Soleas, G.; Goldberg, D. M. The Red Wine Phenolics trans-Resveratrol and Quercetin Block Uman Platelet Aggregation and Eicosanoid Synthesis: Implications for Protection Against Coronary Heart Disease. Clin. Chem. Acta 1995, 235, 207-219.
6. Kimura, Y.; Okuda, H.; Arichi, S. Effects of Stilbenes on Arachidonate Metabolism in Leukocytes. Biochim. Biophys. Acta 1985, 834, 275-278.
7. Belguendouz, L.; Fremont, L.; Gozzellino, M. T. Interaction of trans Resveratrol with Plasma Lipoproteins. Biochem. Pharmacol. 1998, 55, 811-816.
8. Frankel, E. N.; Waterhouse, A. L.; Kinsella, J. E. Inhibition of Human LDL Oxidation by Resveratrol. Lancet 1993, 341, 1103-1104.
9. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. H. S.; Farnworth, R. N.; Kinghorn, A. D.; Metha, R. G.; Moon, R. C.; Pezzuto, J. M. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes. Science 1997, 275, 218-220.
10. Stivala, L. A.; Savio, M.; Carafoli, F.; Perucca, P.; Bianchi, L.; Maga, G.; Forti, L.; Pagoni, U. M.; Albini, A.; Prosperi, E.; Vannini, V. Specific Structural Determinants Are Responsible for the Antioxidant Activity and the Cell Cycle Effects of Resveratrol. J. Biol. Chem. 2001, 276, 22586-22594.
11. Mgbonyebi, O.; Russo, J.; Russo, I. Antiproliferative Effect of Synthetic Resveratrol on Human Breast Epithelial Cells. Int. J. Oncol. 1998, 12, 865-869.
12. Pettit, G. R.; Grealish, M. P.; Jung, M. K.; Hamel, E.; Pettit, R. K.; Chapuis, J. C.; Schmidt, J. M. Antineoplastic Agents. 465. Structural Modification of Resveratrol: Sodium Resveratrin Phosphate. J. Med. Chem. 2002, 45, 2534-2542.
13. Kim, S.; Ko, H.; Park, J. E.; Jung, S.; Lee, S. K.; Chun, Y. J. Design, Synthesis, and Discovery of Novel trans-Stilbene Analogues as Potent and Selective Human Cytochrome P450 1B1 Inhibitors. J. Med. Chem. 2002, 45, 160-164.
14. Thakkar, K.; Geahlen, R. L.; Cushman, M. Synthesis and Protein-Tyrosine Kinase Inhibitory Activity of Polyhydroxylated Stilbene Analogues of Piceatannol. J. Med. Chem. 1993, 36, 2950-2955.
15. Cushman, M.; Nagarathnam, D.; Gopal, D.; He, H. M.; Lin, C. M.; Hamel, E. Synthesis and Evaluation of Analogues of (Z)-1-(4-Methoxyphenyl)-2-(3,4,5-Trimethoxyphenyl)Ethene as Potential Cytotoxic and Antimitotic Agents. J. Med. Chem. 1992, 35, 2293-2306.
16. Clement, M. V.; Hirpara, J. L.; Chawdhury, S. H.; Pervaiz, S. Chemopreventive Agent Resveratrol, a Natural Product Derived from Grapes, Triggers CD95 Signaling-Dependent Apotosis in Human Tumor cells. Blood 1998, 92, 996-1002.
17. Huang, C.; Ma, W. Y.; Goranson, A.; Dong, Z. Resveratrol Suppresses Cell Transformation and Induces Apoptosis through a p53-Dependent Pathway. Carcinogenesis 1999, 20, 237-242.
18. Surh, Y. J.; Hurh, Y. J.; Kang, J. Y.; Lee, E.; Kong, G.; Lee, S. J. Resveratrol, an Antioxidant Present in Red Wine, Induces Apoptosis in Human Promyelocytic Leukemia (HL-60) Cells. Cancer Lett. 1999, 140, 1-10.
19. Arens, M. J.; Wyllie, A. H. Apoptosis: Mechanism and Roles in Pathology. Int. Rev. Exp. Pathol. 1991, 32, 223-254.
20. Daniel, P. T. Dissecting the Pathways to Death. Leukemia 2000, 14, 2035-2044.
21. Hickman, J. A. Apoptosis and Chemotherapy Resistance. Eur. J. Cancer 1996, 32A, 921-926.
22. Hannun, Y. A. Apoptosis and the Dilemma of Cancer Chemotherapy. Blood 1997, 89, 1845-1853.
23. Prokop, A.; Wieder, T.; Sturm, I.; Essman, F.; Seeger, K.; Wutcher, C.; Ludwig, W.-D. Henze, G.; Dörken, B.; Daniel, P. T. Relapse in Childhood Acute Lymphoblastic Leukemia Is Associated with a Decrease of the Bax/Bcl-2-Ratio and Loss of Spontaneous Caspase-3 Processing in Vivo. Leukemia 2000, 14, 1606-1613.
24. Raisova, M.; Bektas, M.; Wieder, T.; Daniel, P.; Eberle, J.; Orfanos, C. E.; Geilen, C. C. Resistance to CD95/Fas-Induced and Ceramide-Mediated Apoptosis of Human Melanoma Cells Is Caused by a Defective Mitochondrial Cytochrome C Release. FEBS Lett. 2000, 473, 27-32.
25. Simoni, D.; Tolomeo, M. Retinolds, Apoptosis and Cancer. Curr. Pharm. Des. 2001, 7, 1823-1837 and references therein.
26. Tolomeo, M.; Simoni, D. Drug Resistance and Apoptosis in Cancer Treatment: Development of New Apoptosis-Inducing Agents Active in Drug Resistant Malignancies. Curr. Med. Chem.: Anti-Cancer Agents 2002, 2, 387-406 and references therein.
27. Simoni, D.; Roberti, M.; Invidiata, F. P.; Rondanin, R.; Baruchello, R.; Malagutti, C.; Mazzali, A.; Rossi, M.; Grimaudo, S.; Dusonchet, L.; Meli, M.; Raimondi, M. V.; D'Alessandro, N.; Tolomeo, M. Programmed Cell Death (PCD) Associated with the Stilbene Motif of Arotinoids: Discovery of Novel Apoptosis Inducer Agents Possessing Activity on Multidrug Resistant Tumor Cells. Bioorg. Med. Chem. Lett. 2000, 10, 2669-2673.
28. Simoni, D.; Roberti, M.; Invidiata, F. P.; Rondanin, R.; Baruchello, R.; Malagutti, C.; Mazzali, A.; Rossi, M.; Grimaudo, S.; Capone, F.; Dusonchet, L.; Meli, M.; Raimondi, M. V.; Landino, M.; D'Alessandro, N.; Tolomeo, M.; Arindam, D.; Lu, S.; Benbrook, D. M. Heterocycle-Containing Retinoids. Discovery of a Novel Isoxazole Arotinoid Possessing Potent Apoptotic Activity in Multidrug and Drug-Induced Apoptosis-Resistant Cells. J. Med. Chem. 2001, 44, 2308-2318.
29. Tan, B.; Piwnica-Worms, D.; Ratner, L. Multidrug Resistance Transporters and Modulation. Curr. Opin. Oncol. 2000, 12, 450-458.
30. Deffie, A. M.; Batra, J. K.; Goldenberg, G. J. Direct Correlation between DNA Topoisomerase II Activity and Cytotoxicity in Adriamycin-Sensitive and -Resistant P388 Leukemia Cell Lines. Cancer Res. 1989, 49, 58-62.
31. Sanguedolce, M. R.; Alessandro, R.; De Leo, G.; Gullotti, L.; Sanguedolce, F.; Vultaggio, G.; Diana, G.; Cirello, B.; Rausa, L. Failure of Detection of the Tyrosine to Histidine Substitution at the Residue 33 of Thymidilate Synthase in Human Colorectal Cancer. A Preliminary Study. Anticancer Res. 2000, 20, 4347-4350.
32. Dalton, W. S.; Crowley, J. J.; Salmon, S. S.; Grogan, T. M.; Laufman, L. R.; Weiss, G. R.; Bonnet, J. D. A Phase-III Randomized Study of Oral Verapamil as a Chemosensitizer To Reverse Drug Resistance in Patients with Refractory Myeloma. A Southwest Oncology Group Study. Cancer 1995, 75, 815-820.
33. Milroy, R. A Randomized Clinical Study of Verapamil in Addition to Combination Chemotherapy in Small Cell Lung Cancer. West of Scotland Lung Cancer Research Group and the Aberdeen Oncology Group. Br. J. Cancer 1993, 68, 813-818.
34. Wishart, G. C.; Bissett, D.; Paul, J.; Jodrell, D.; Harnett, A.; Habeshaw, T.; Kerr, D. J.; Macham, M. A.; Soukop, M.; Leonard, R. C. J. Quinidine as a Resistance Modulator of Epirubicin in Advanced Breast Cancer: Mature Results of a Placebo-Controlled Randomized Trial. Clin. Oncol. 1994, 12, 1771-1777.
35. Covelli, A. Modulation of Multidrug Resistance (MDR) in Hematological Malignancies. Ann. Oncol. 1999, 10 (Suppl. 6), 53-59.
36. Pettit, G. R.; Singh, S. B.; Niven, M. L.; Hamel, F.; Schmidt, J. M. Isolation, Structure, and Synthesis of Combretastatins A-1 and B-1, Potent New Inhibitors of Microtubule Assembly, Derived from Combretum Coffrum. J. Nat. Prod. 1987, 50 (1), 119-131.
37. Orsini, F.; Pelizzoni, F.; Bellini, B.; Miglierini, G. Synthesis of Biologically Active Polyphenolic Glycosides (Combretastatin and Resveratrol Series). Carbohydr. Res. 1997, 301, 95-109.
38. Cardona, M. L.; Fernandez, M. I.; Garcia, M. B.; Pedro, J. R. Synthesis of Natural Polhydroxystilbenes. Tetrahedron 1986, 42, 2725-2730.
39. Reimann, E. Natürliche Stilbene. Synthese von Polyhydroxystil-benäthern durch Wittig-Reaktion (Natural Stilbenes. Synthesis of Polyhydroxystilbene Ethers through the Wittig Reaction). Chem. Ber. 1969, 102, 2881-2888.
40. Chiaki, T.; Masaomi, S. Manufacture of Nitro and Amino Compounds Used for Electrophotographic Photoreceptor. Jpn. Kokai Tokkyo Koho 1995 (Application JP 94-59659 19940330).
41. Jayatilake, G. S.; Jayasuriya, H.; Lee, E. S.; Koonchanok, N. M.; Geahlen, R. L.; Ashendel, C. L.; McLaughlin, J. L.; Chang, C. J. Kinase Inhibitors from Polygonum Cuspidatum. J. Nat. Prod. 1993, 56, 1805-1810.
42. Kashiwada, Y.; Nonaka, G.; Nishioka, I. Studies on Rhubarb (Rhei Rhizoma). VI. Isolation and Characterization of Stilbenes. Chem. Pharm. Bull. 1984, 32, 3501-3517.
43. Späth, E.; Schläger, J. Über die Inhaltsstoffe des roten Sandelholzels. II. Mitteil.: Die Konstitution des Pterostilbens (On the Contents of Red Sandalwood. Part 2. The Constitution of Pterostilbene). Chem. Ber. 1940, 73, 881-884.
44. Gill, M. T.; Bajaj, R.; Chang, C. J.; Nichols, D. E.; McLaughlin, J. L. 3,3′,5′-Tri-O-methylpiceatannol and 4,3′,5′-Tri-O-methylpiceatannol: Improvements over Piceatannol in Bioactivity. J. Nat. Prod. 1987, 50, 36-40.
45. Pettit, G. R.; Singh, S. B.; Isolation and Synthesis of Combretastatins as Neoplasm Inhibitors. Eur. Pat. Appl. 1998 (Application: EP 88-300064 19880106).
46. Ma, Z.; Li, X.; Li, N.; Wang, J. Stilbenes from Sphaerophysa salsula. Fitoterapia 2002, 73, 313-315.